SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-004558
Filing Date
2024-01-18
Accepted
2024-01-18 16:54:39
Documents
1
Period of Report
2023-11-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2112
  Complete submission text file 0001213900-24-004558.txt   3822
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Issuer) CIK: 0001840563 (see all company filings)

IRS No.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2615 Q STREET, #1 SACRAMENTO CA 95816
Business Address 2615 Q STREET, #1 SACRAMENTO CA 95816 866-794-4940
JP Bio Consulting LLC (Reporting) CIK: 0002003776 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41875 | Film No.: 24542471